MentionFox
Home › funding signals › REVNA BIOSCIENCES, INC.
Form D · on the record

REVNA BIOSCIENCES — Form D filing, December 2024

Before you sell to, join or invest in REVNA BIOSCIENCES, INC.

MentionFox check on REVNA BIOSCIENCES, INC.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/revna-biosciences-inc-form-d-24000001

Check REVNA BIOSCIENCES, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about REVNA BIOSCIENCES, INC.?

REVNA BIOSCIENCES, INC. filed a Form D with the Securities and Exchange Commission on 2024-12-31.

REVNA BIOSCIENCES, INC. filed a Form D notice of an exempt securities offering with the SEC on December 31, 2024. Its industry group is Biotechnology. It names Derrick Akpalu (Executive Officer) (SEC Form D, December 31, 2024).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

2 more Biotechnology raises in Pennsylvania within 90 days ↓

Is this your company?

Key facts

Run the free check on REVNA BIOSCIENCES, INC. →

Sell to companies like REVNA BIOSCIENCES, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

REVNA BIOSCIENCES, INC.

New Form D on file · 2024-12-31 · the record

$0
raise on the record
D
filing
0
investors in
PENNSYLVANIA
based
Open the record →

What the record says

FilingForm D
Filed2024-12-31
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedHORSHAM, PENNSYLVANIA
CIK2048552
Accession0002048552-24-000001

Pitching, partnering or investing alongside them? See who really runs and owns REVNA BIOSCIENCES, INC.

Free to see. No signup.

Keep reading

More on the people and the money behind REVNA BIOSCIENCES, INC., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.

What do you want to do with REVNA BIOSCIENCES, INC.?

Get the full cited report on REVNA BIOSCIENCES, INC.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on REVNA BIOSCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives REVNA BIOSCIENCES, INC.'s address as 300 Welsh Road, Building One, Suite 100, Horsham, PA 19044.

What the filing says

  • Offered: $1,900,000. Sold: nothing yet. Left to sell: $1,900,000. (filing)
  • Investors: 0 had already invested. (filing)
  • Date of first sale: yet to occur. (filing)
  • Types of securities: Other: Convertible Notes. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on REVNA BIOSCIENCES, INC. See pricing

Is REVNA BIOSCIENCES, INC. a real, registered company?

REVNA BIOSCIENCES, INC. is a registered filer with the SEC (CIK 2048552) and has filed since 2024-12-31. 1 filing is on record, the latest on 2024-12-31.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs REVNA BIOSCIENCES, INC.?

REVNA BIOSCIENCES, INC.'s Form D of 2024-12-31 names Derrick Akpalu as its officers, directors or promoters.

Biotechnology · by week

Trailing twelve months. 763 filings in Biotechnology, totalled by week.

Want the whole picture on REVNA BIOSCIENCES, INC.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on REVNA BIOSCIENCES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on REVNA BIOSCIENCES, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind REVNA BIOSCIENCES, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for REVNA BIOSCIENCES, INC.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/revna-biosciences-inc-form-d-24000001
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2
REVNA BIOSCIENCES — SEC Form D filing, December 2024. MentionFox, 2026-11-06. https://mentionfox.com/funding/revna-biosciences-inc-form-d-24000001